
News|Articles|July 1, 2006
Antihypertensives demonstrate benefit in reducing Alzheimer's disease risk
Potassium-sparing diuretics reduced the risk of Alzheimer's disease (AD) by >70% in patients aged >64 years while other antihypertensive (AH) medications, including all diuretics, beta blockers, and dihydropyridine calcium channel blockers, were linked with somewhat smaller decreases in Alzheimer's risk.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Patient-facing EHR tool improves lung cancer screening identification
2
How California is rewriting the PBM playbook
3
Study highlights high costs, treatment challenges for older adults with HER2-positive advanced gastric cancer
4
New therapies on the way to lower Lp(a), a cardiovascular risk factor
5





















































